Elevance Health Financing Cash Flow decreased by 1135.0% to -$2.52B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 31.7%, from -$1.91B to -$2.52B. Over 2 years (FY 2022 to FY 2024), Financing Cash Flow shows an upward trend with a -4.9% CAGR.
A large negative value typically indicates a company is returning capital to shareholders or paying down debt, while a positive value suggests the company is raising external capital to fund operations or acquisitions.
This metric represents the net flow of cash between a company and its capital providers, including shareholders and lend...
Large-cap peers like Microsoft or Alphabet similarly show large negative financing outflows due to aggressive share repurchase programs and dividend distributions.
net_cash_from_financing| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$820.00M | -$830.00M | $322.00M | -$127.00M | -$1.26B | -$258.00M | -$531.00M | -$1.43B | -$994.00M | -$394.00M | $32.00M | $668.00M | -$915.00M | $1.41B | -$1.91B | -$308.00M | $243.00M | -$2.52B |
| QoQ Change | — | -1.2% | +138.8% | -139.4% | -888.2% | +79.4% | -105.8% | -169.3% | +30.5% | +60.4% | +108.1% | >999% | -237.0% | +253.9% | -235.6% | +83.9% | +178.9% | <-999% |
| YoY Change | — | — | — | +84.5% | -51.2% | — | -264.9% | <-999% | +20.8% | -52.7% | +106.0% | +146.7% | +7.9% | +457.4% | <-999% | -146.1% | +126.6% | -31.7% |